Patents by Inventor Tetsuo Nishikawa

Tetsuo Nishikawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200024388
    Abstract: A polyester resin composition includes a copolymer of a polycarboxylic acid component and a polyol component. The polycarboxylic acid component includes terephthalic acid and/or a derivative thereof The polyol component includes ethylene glycol and/or a derivative thereof and 2,2-dimethyl-1,3-propanediol and/or a derivative thereof. A content by percentage of 2,2-dimethyl-1,3-propanediol and/or the derivative thereof is 27 mol % to 55 mol % based on the total amount of the polyol component. The composition has an intrinsic viscosity of 0.5 dl/g to 0.6 dl/g.
    Type: Application
    Filed: August 22, 2017
    Publication date: January 23, 2020
    Inventors: Yusuke ITO, Tomomitsu UENO, Hideaki TOMURA, Masahiro YAMA, Tetsuo NISHIKAWA, Toshio HONMA
  • Patent number: 8110662
    Abstract: A cDNA fragment participating in the maintenance of smooth muscle differentiation was isolated using a culture system of chicken gizzard smooth muscle cells, the differential display method and the subtracted hybridization method. Using the obtained cDNA sequence as a query, cDNA sequences of Helix Research Institute (Japanese Patent Application No. 2000-118776) were retrieved, and thus, a novel gene “C-NT2RP3001495” was obtained. The protein encoded by this gene has two WW domains that participate in protein interactions in the N-terminal domain. Evidence suggests that this protein binds to other proteins, and thus regulates the intracellular signal transduction, gene expression, and so on, thereby participating in the maintenance of the differentiation of smooth muscle cells. This protein and compounds regulating the expression thereof are markedly useful in developing drugs for various diseases associated with abnormality in the maintenance of smooth muscle cell differentiation.
    Type: Grant
    Filed: October 9, 2007
    Date of Patent: February 7, 2012
    Assignees: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Koji Hayashi, Kaoru Otsuka, Jun-Ichi Yamamoto, Shizuko Ishii, Tomoyasu Sugiyama, Ai Wakamatsu, Keiichi Nagai, Tetsuji Otsuki, Shin-Ichi Funahashi, Shoji Miyata, Kenji Sobue, Kenichiro Hayashi
  • Patent number: 7668344
    Abstract: (A) Luminance data is prepared. (B) A group of first order differential values is obtained from luminance values of said luminance data along a first direction, a group of second order differential values is obtained from the group of first order differential values, and first data is output in accordance with the group of second order differential values. There is provided a stain inspection method having high inspection correctness.
    Type: Grant
    Filed: February 9, 2006
    Date of Patent: February 23, 2010
    Assignee: Fujifilm Corporation
    Inventors: Ichiro Matsumoto, Tetsuo Nishikawa
  • Patent number: 7354968
    Abstract: The present invention provides a thermoplastic resin composition having a high specific gravity, flexibility and excellent processability that can be used as a material for forming various articles requiring both massiveness and flexibility. This thermoplastic resin composition contains 2.5 to 15 wt % of a styrene-based thermoplastic elastomer and 85 to 97.5 wt % of tungsten powder, and an molded article is obtained by melting and kneading this thermoplastic resin composition. This article can be used preferably as a balance weight attached to a wheel of an automobile, sports goods or the like.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: April 8, 2008
    Assignee: Sumitomo Rubber Industries, Ltd.
    Inventors: Tetsuo Nishikawa, Kazuo Haruta, Toshiaki Sakaki, Tetsuo Mizoguchi
  • Publication number: 20080069826
    Abstract: A cDNA fragment participating in the maintenance of smooth muscle differentiation was isolated using a culture system of chicken gizzard smooth muscle cells, the differential display method and the subtracted hybridization method. Using the obtained cDNA sequence as a query, cDNA sequences of Helix Research Institute (Japanese Patent Application No. 2000-118776) were retrieved, and thus, a novel gene “C-NT2RP3001495” was obtained. The protein encoded by this gene has two WW domains that participate in protein interactions in the N-terminal domain. Evidence suggests that this protein binds to other proteins, and thus regulates the intracellular signal transduction, gene expression, and so on, thereby participating in the maintenance of the differentiation of smooth muscle cells. This protein and compounds regulating the expression thereof are markedly useful in developing drugs for various diseases associated with abnormality in the maintenance of smooth muscle cell differentiation.
    Type: Application
    Filed: October 9, 2007
    Publication date: March 20, 2008
    Inventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Koji Hayashi, Kaoru Otsuka, Jun-Ichi Yamamoto, Shizuko Ishii, Tomoyasu Sugiyama, Ai Wakamatsu, Keiichi Nagai, Tetsuji Otsuki, Shin-Ichi Funahashi, Shoji Miyata, Kenji Sobue, Kenichiro Hayashi
  • Patent number: 7279558
    Abstract: A cDNA fragment participating in the maintenance of smooth muscle differentiation was isolated using a culture system of chicken gizzard smooth muscle cells, the differential display method and the subtracted hybridization method. Using the obtained cDNA sequence as a query, cDNA sequences of Helix Research Institute (Japanese Patent Application No. 2000-118776) were retrieved, and thus, a novel gene “C-NT2RP3001495” was obtained. The protein encoded by this gene has two WW domains that participate in protein interactions in the N-terminal domain. Evidence suggests that this protein binds to other proteins, and thus regulates the intracellular signal transduction, gene expression, and so on, thereby participating in the maintenance of the differentiation of smooth muscle cells. This protein and compounds regulating the expression thereof are markedly useful in developing drugs for various diseases associated with abnormality in the maintenance of smooth muscle cell differentiation.
    Type: Grant
    Filed: February 4, 2005
    Date of Patent: October 9, 2007
    Assignees: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Koji Hayashi, Kaoru Otsuka, Jun-Ichi Yamamoto, Shizuko Ishii, Tomoyasu Sugiyama, Ai Wakamatsu, Keiichi Nagai, Tetsuji Otsuki, Shin-Ichi Funahashi, Shoji Miyata, Kenji Sobue, Kenichiro Hayashi
  • Patent number: 7217800
    Abstract: A cDNA encoding a novel LTC4 receptor has been isolated. Provision of the novel protein, an LTC4 receptor, enabled binding experiments using the LTC4. By screening for compounds that modulate LTC4 receptor activity based on these binding experiments, development of drugs targeting the LTC4 receptor becomes possible.
    Type: Grant
    Filed: September 2, 2004
    Date of Patent: May 15, 2007
    Assignees: Astellas Pharma Inc., Helix Research Institute
    Inventors: Jun Takasaki, Masazumi Kamohara, Mitsuyuki Matsumoto, Tetsu Saito, Tohru Sugimoto, Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Yuri Kawai
  • Publication number: 20070105122
    Abstract: Primers for synthesizing full-length cDNAs and their use are provided. 5602 cDNA encoding a human protein has been isolated and nucleotide sequences of 5?-, and 3?-ends of the cDNA have been determined. Furthermore, primers for synthesizing the full-length cDNA have been provided to clarify the function of the protein encoded by the cDNA. The full-length cDNA of the present invention containing the translation start site provides information useful for analyzing the functions of the protein.
    Type: Application
    Filed: August 13, 2004
    Publication date: May 10, 2007
    Inventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Koji Hayashi, Kaoru Saito, Junichi Yamamoto, Shizuko Ishii, Tomoyasu Sugiyama, Ai Wakamatsu, Keiichi Nagai, Tetsuji Otsuki
  • Publication number: 20070082345
    Abstract: Novel human secretory proteins or membrane proteins, and full length cDNAs encoding the proteins are provided. 173 kinds of novel proteins and polynucleotides encoding these proteins have been isolated. The proteins of the present invention are useful as candidates for medicines or as target molecules for developing medicines. The polynucleotides of the present invention are used to produce these proteins.
    Type: Application
    Filed: May 8, 2006
    Publication date: April 12, 2007
    Inventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Yuri Kawai, Tomoyasu Sugiyama, Koji Hayashi
  • Publication number: 20070048740
    Abstract: Novel full-length cDNAs are provided. 1,995 cDNA derived from human have been isolated. The full-length nucleotide sequences of the cDNA and amino acid sequences encoded by the nucleotide sequences have been determined. Because the cDNA of the present invention are full-length and contain the translation start site, they provide information useful for analyzing the functions of the polypeptide.
    Type: Application
    Filed: February 13, 2004
    Publication date: March 1, 2007
    Inventors: Takao Isogai, Junichi Yamamoto, Tetsuo Nishikawa, Yuko Isono, Tomoyasu Sugiyama, Tetsuji Otsuki, Ai Wakamatsu, Shizuko Ishii, Keiichi Nagai, Ryotaro Irie
  • Publication number: 20060287831
    Abstract: One of a plurality of data display formats with different units of correlation data that are prepared in advance is automatically selected depending on the variation of the amount of data in terms of the number of items thereof. One of a plurality of display methods with different summarization levels that are prepared in advance is also automatically selected for information (about correlation data or individual events) regarding individual cells. Information about the correlation data and individual cells is then displayed. The amount of work required to repeat the operation of observing the correlation data as a whole and the detailed observation of a small amount of data is reduced in a method for visualizing correlation data concerning two events in a matrix format.
    Type: Application
    Filed: July 12, 2004
    Publication date: December 21, 2006
    Inventors: Motoi Totiba, Tetsuo Nishikawa, Ken Horiuchi, Masashi Nemoto, Kenji Araki
  • Patent number: 7129338
    Abstract: Human cDNA encoding a secretory or membrane protein useful as a candidate for developing medicine or as a target molecule for developing medicine. The expression level of the polynucleotide of the present invention increased in NT2 cells after retinoic acid-treatment. Accordingly, this cDNA is associated neurological disease.
    Type: Grant
    Filed: November 27, 2002
    Date of Patent: October 31, 2006
    Assignee: Research Association for Biotechnology
    Inventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Yuri Kawai, Tomoyasu Sugiyama, Koji Hayashi
  • Publication number: 20060193497
    Abstract: (A) Luminance data is prepared. (B) A group of first order differential values is obtained from luminance values of said luminance data along a first direction, a group of second order differential values is obtained from the group of first order differential values, and first data is output in accordance with the group of second order differential values. There is provided a stain inspection method having high inspection correctness.
    Type: Application
    Filed: February 9, 2006
    Publication date: August 31, 2006
    Applicant: Fuji Photo Film Co., Ltd.
    Inventors: Ichiro Matsumoto, Tetsuo Nishikawa
  • Patent number: 7085651
    Abstract: An object of the present invention is to perform the clustering and assembling of nucleic acid base sequences at a high speed. Partial sequences 102 are extracted from each input sequence 101 and entered into a fixed-length partial sequence table 103. In the case where a sequence overlapping with a consensus sequence 104 is searched while making reference to the fixed-length partial sequence table 103 and consequently a partial sequence 102, which exactly matches with a sequence defined by a fixed length window 105 scanning along the consensus sequence, is found to be present, whether the whole input sequence can be assembled or not is determined by comparing the sequences. If it is possible to assemble the sequences, they are assembled into a consensus sequence and also joined into the same cluster. The clustering and assembling are performed by repeatedly processing this procedure based on greedy method until no unprocessed input nucleic acid base sequence is left.
    Type: Grant
    Filed: February 27, 2002
    Date of Patent: August 1, 2006
    Assignee: Hitachi, Ltd.
    Inventors: Tomohiro Yasuda, Tetsuo Nishikawa
  • Patent number: 7047255
    Abstract: The present invention visualizes the contents of a plurality of documents without a lack of the listing property. Two document units are extracted from a document database and relevance degrees between individual elements of a group of the document units are calculated. The results are displayed on a two-dimensional coordinate plane depending on the relevance degree.
    Type: Grant
    Filed: February 27, 2003
    Date of Patent: May 16, 2006
    Assignee: Hitachi, Ltd.
    Inventors: Osamu Imaichi, Tetsuo Nishikawa, Toru Hisamitsu, Makoto Iwayama, Masakazu Fujio
  • Patent number: 7029860
    Abstract: The present invention provides: proteins suppressing or promoting the aggregation or deposition of amyloid-? protein; polynucleotides encoding the proteins; a method for screening a compound suppressing or promoting the aggregation or deposition of amyloid-? protein; and therapeutic agents for treating or preventing Alzheimer's diseases comprising a compound that regulates the activity of a protein suppressing or promoting the aggregation or deposition of amyloid-? protein.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: April 18, 2006
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Yuri Hio, Mayako Yamazaki, Susumu Satoh, Hiroyuki Arakawa, Masahiko Morita
  • Patent number: 7010141
    Abstract: In a speaker device 10 having: a magnetic circuit 13 including a magnet 14 and a yoke 11; a voice coil 16 which is placed in a magnetic gap 12 of the magnetic circuit 13; and a diaphragm 17 which is vibrating available in a state where the diaphragm is coupled with the voice coil 16, a peripheral edge of the diaphragm 17 being fixed to a housing 20, a damper holder 30 is disposed in a portion where a damper 27 is attached to the housing 20. The damper holder 30 is in point contact with the housing 20 via three or more projections 31 which are disposed on one of the damper holder 30 and the housing 20. Preferably, the damper holder 30 is made of a hybrid material of a resin (polypropylene) and tungsten, and has a specific gravity of 10.0 or larger.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: March 7, 2006
    Assignees: Pioneer Corporation, Tohoku Pioneer Corporation
    Inventors: Hideaki Sugiura, Taizo Nakata, Tetsuo Nishikawa
  • Publication number: 20050250144
    Abstract: Selection of clones having the kinase and/or phosphatase-like structure from clones which had been isolated and the structures thereof had been determined in the Helix Research Institute (helix clones; Japanese Patent Application No. 2000-183767) was conducted. Two novel genes were provided by carrying out homology search for all the helix clones by using the amino acid sequences of known kinases and phosphatases as queries. The genes are expected to be involved in intracellular signal transduction. The physiological functions of the inventive genes can be tested by using reporter gene assay systems capable of detecting signal transduction. The proteins of the present invention are useful as target molecules in drug discovery and in the development of new pharmaceuticals.
    Type: Application
    Filed: April 19, 2005
    Publication date: November 10, 2005
    Inventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Koji Hayashi, Kaoru Otsuka, Jun-Ichi Yamamoto, Shizuko Ishii, Tomoyasu Sugiyama, Ai Wakamatsu, Keiichi Nagai, Tetsuji Otsuki, Shin-Ichi Funahashi, Chiaki Senoo, Jin-Ichi Nezu
  • Patent number: 6960435
    Abstract: The present invention provides: proteins suppressing or promoting the aggregation or deposition of amyloid-? protein; polynucleotides encoding the proteins; a method for screening a compound suppressing or promoting the aggregation or deposition of amyloid-? protein; and therapeutic agents for treating or preventing Alzheimer's diseases comprising a compound that regulates the activity of a protein suppressing or promoting the aggregation or deposition of amyloid-? protein.
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: November 1, 2005
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Yuri Hio, Mayako Yamazaki, Susumu Satoh, Hiroyuki Arakawa, Masahiko Morita
  • Publication number: 20050214813
    Abstract: The present invention provides: proteins suppressing or promoting the aggregation or deposition of amyloid-? protein; polynucleotides encoding the proteins; a method for screening a compound suppressing or promoting the aggregation or deposition of amyloid-? protein; and therapeutic agents for treating or preventing Alzheimer's diseases comprising a compound that regulates the activity of a protein suppressing or promoting the aggregation or deposition of amyloid-? protein.
    Type: Application
    Filed: December 17, 2004
    Publication date: September 29, 2005
    Applicant: Fujisawa Pharmaceutical Co. Ltd.
    Inventors: Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Yuri Hio, Mayako Yamazaki, Susumu Satoh, Hiroyuki Arakawa, Masahiko Morita